Published in Transl Psychiatry on December 04, 2012
Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder | NCT02660528
Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc Natl Acad Sci U S A (2014) 1.50
Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav Immun (2015) 1.10
Surveillance, phagocytosis, and inflammation: how never-resting microglia influence adult hippocampal neurogenesis. Neural Plast (2014) 1.07
Associations between cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression in patients prior to breast cancer surgery. Biol Res Nurs (2014) 0.93
Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses. Front Cell Neurosci (2013) 0.92
IL-6 regulation of synaptic function in the CNS. Neuropharmacology (2014) 0.91
Long-term effects of maternal immune activation on depression-like behavior in the mouse. Transl Psychiatry (2014) 0.88
Neurobiology of major depressive disorder. Neural Plast (2013) 0.86
The role of brain-derived neurotrophic factor in comorbid depression: possible linkage with steroid hormones, cytokines, and nutrition. Front Psychiatry (2014) 0.85
STAT3 controls IL6-dependent regulation of serotonin transporter function and depression-like behavior. Sci Rep (2015) 0.85
Inflammatory cytokine-associated depression. Brain Res (2014) 0.84
Peripheral and Central Mechanisms of Stress Resilience. Neurobiol Stress (2015) 0.84
Long-lasting recognition memory impairment and alterations in brain levels of cytokines and BDNF induced by maternal deprivation: effects of valproic acid and topiramate. J Neural Transm (Vienna) (2014) 0.83
Cytokine variations and mood disorders: influence of social stressors and social support. Front Neurosci (2014) 0.83
The development of depression-like behavior is consolidated by IL-6-induced activation of locus coeruleus neurons and IL-1β-induced elevated leptin levels in mice. Psychopharmacology (Berl) (2015) 0.83
Integrating Interleukin-6 into depression diagnosis and treatment. Neurobiol Stress (2016) 0.83
Controversies about a common etiology for eating and mood disorders. Front Psychol (2014) 0.81
Rodent models of depression: neurotrophic and neuroinflammatory biomarkers. Biomed Res Int (2014) 0.81
Interleukin-6 amplifies glucagon secretion: coordinated control via the brain and pancreas. Am J Physiol Endocrinol Metab (2014) 0.81
Inflammation, psychiatric symptoms, and opioid use are associated with pain and disability in patients with cirrhosis. Clin Gastroenterol Hepatol (2014) 0.79
Transgenic mice with increased astrocyte expression of IL-6 show altered effects of acute ethanol on synaptic function. Neuropharmacology (2015) 0.79
The rapid antidepressant effect of ketamine in rats is associated with down-regulation of pro-inflammatory cytokines in the hippocampus. Ups J Med Sci (2015) 0.79
PDE11A negatively regulates lithium responsivity. Mol Psychiatry (2016) 0.78
Differential and converging molecular mechanisms of antidepressants' action in the hippocampal dentate gyrus. Neuropsychopharmacology (2014) 0.78
Vagal nerve stimulation blocks interleukin 6-dependent synaptic hyperexcitability induced by lipopolysaccharide-induced acute stress in the rodent prefrontal cortex. Brain Behav Immun (2014) 0.78
Effort-related motivational effects of the pro-inflammatory cytokine interleukin-6: pharmacological and neurochemical characterization. Psychopharmacology (Berl) (2016) 0.78
Knockdown of hippocampal cysteinyl leukotriene receptor 1 prevents depressive behavior and neuroinflammation induced by chronic mild stress in mice. Psychopharmacology (Berl) (2015) 0.77
An altered peripheral IL6 response in major depressive disorder. Neurobiol Dis (2016) 0.77
IFN-γ differentially modulates memory-related processes under basal and chronic stressor conditions. Front Cell Neurosci (2014) 0.77
Dietary inflammatory index and recurrence of depressive symptoms: Results from the Whitehall II Study. Clin Psychol Sci (2016) 0.76
Elevation of Il6 is associated with disturbed let-7 biogenesis in a genetic model of depression. Transl Psychiatry (2016) 0.76
The role of interleukin genes in the course of depression. Open Med (Wars) (2016) 0.75
Rodent models of treatment-resistant depression. Eur J Pharmacol (2014) 0.75
Sirukumab: A Potential Treatment for Mood Disorders? Adv Ther (2016) 0.75
CSF-1R inhibition attenuates renal and neuropsychiatric disease in murine lupus. Clin Immunol (2016) 0.75
Antidepressant-Like Effect of Lipid Extract of Channa striatus in Chronic Unpredictable Mild Stress Model of Depression in Rats. Evid Based Complement Alternat Med (2016) 0.75
The translational aspect of complementary and alternative medicine for cancer with particular emphasis on Kampo. Front Pharmacol (2015) 0.75
Depression-like Behavior Induced by Nesfatin-1 in Rats: Involvement of Increased Immune Activation and Imbalance of Synaptic Vesicle Proteins. Front Neurosci (2015) 0.75
Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy. J Psychopharmacol (2017) 0.75
From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 15.90
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry (2006) 12.41
Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol (2005) 8.49
The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) (1985) 7.53
A meta-analysis of cytokines in major depression. Biol Psychiatry (2009) 7.16
Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med (2009) 7.06
Biological basis of the behavior of sick animals. Neurosci Biobehav Rev (1988) 5.03
Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun (2006) 4.55
IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc Natl Acad Sci U S A (2008) 3.19
Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry (2005) 3.00
Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci (2001) 2.93
The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav Immun (2001) 2.89
Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci U S A (1993) 2.81
Cytokine-induced sickness behavior. Brain Behav Immun (2003) 2.70
In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry (2004) 2.55
Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine (1997) 2.43
Sickness behavior as a new target for drug development. Trends Pharmacol Sci (1992) 2.42
Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry (1995) 2.35
The macrophage theory of depression. Med Hypotheses (1991) 2.18
The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology (2011) 2.15
The STAR*D Project results: a comprehensive review of findings. Curr Psychiatry Rep (2007) 2.08
Constant darkness induces IL-6-dependent depression-like behavior through the NF-κB signaling pathway. J Neurosci (2011) 1.96
Interleukin-6 and chemokines in the neuropsychiatric manifestations of systemic lupus erythematosus. Arthritis Rheum (2007) 1.95
Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry (2007) 1.93
Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs (2005) 1.93
Major depression and activation of the inflammatory response system. Adv Exp Med Biol (1999) 1.84
Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity. Biol Psychiatry (2009) 1.72
Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology (Berl) (2006) 1.63
The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol (2000) 1.60
High affinity interleukin-6 receptor is a hexameric complex consisting of two molecules each of interleukin-6, interleukin-6 receptor, and gp-130. J Biol Chem (1994) 1.57
Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res (2006) 1.46
Cytokine imbalance in the pathophysiology of major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.40
Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci (1995) 1.36
A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol (2007) 1.36
IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors. Neurobiol Dis (2006) 1.33
Cytokines and sickness behavior. Ann N Y Acad Sci (1998) 1.32
Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies. Neurobiol Dis (2009) 1.22
IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol (2005) 1.20
Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res (1994) 1.20
The effects of psychological stress on plasma interleukin-6 activity in rats. Physiol Behav (1990) 1.17
Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning. Brain Res (1993) 1.15
Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats. Am J Physiol (1999) 1.14
Synergistic effects of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha: central monoamine, corticosterone, and behavioral variations. Neuropsychopharmacology (2000) 1.14
Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat. Brain Behav Immun (1995) 1.13
Central administration of lipopolysaccharide induces depressive-like behavior in vivo and activates brain indoleamine 2,3 dioxygenase in murine organotypic hippocampal slice cultures. J Neuroinflammation (2010) 1.11
An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience (1998) 1.03
Etiology and pathogenesis of a spontaneous lupus-like syndrome in mice. Arthritis Rheum (1978) 1.03
Housing conditions and stimulus females: a robust social discrimination task for studying male rodent social recognition. Nat Protoc (2009) 1.01
Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy. J Clin Psychiatry (2006) 0.99
Higher plasma interleukin-6 (IL-6) level is associated with SSRI- or SNRI-refractory depression. Prog Neuropsychopharmacol Biol Psychiatry (2009) 0.99
The MRL/lpr mouse strain as a model for neuropsychiatric systemic lupus erythematosus. J Biomed Biotechnol (2011) 0.97
Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6. Brain Res Bull (1997) 0.95
Depression is an early disease manifestation in lupus-prone MRL/lpr mice. J Neuroimmunol (2009) 0.94
Abnormal splenic and thymic IL-4 and TNF-alpha expression in MRL-lpr/lpr mice. Scand J Immunol (1995) 0.91
Effects of lipopolysaccharide on food-motivated behavior in the rat are not blocked by an interleukin-1 receptor antagonist. Neurosci Lett (1992) 0.88
Prolonged depression-like behavior caused by immune challenge: influence of mouse strain and social environment. PLoS One (2011) 0.87
IL-6 mediated alterations on immobile behavior of rats in the forced swim test via ERK1/2 activation in specific brain regions. Behav Brain Res (2008) 0.84
Aberrant cytokine gene expression in the hippocampus in murine systemic lupus erythematosus. Neurosci Lett (2001) 0.83
The expressions of mRNAs for interleukin-6 (IL-6) and the IL-6 receptor (IL-6R) in the rat hypothalamus and midbrain during restraint stress. Life Sci (1998) 0.83
The effect of chronic mild stress on tumor-bearing rats' behavior and its mechanism. Neurosci Lett (2009) 0.82
The influence of restraint stress on the expression of mRNAs for IL-6 and the IL-6 receptor in the hypothalamus and midbrain of the rat. Life Sci (1997) 0.82
Behavior and pro-inflammatory cytokine variations among submissive and dominant mice engaged in aggressive encounters: moderation by corticosterone reactivity. Front Behav Neurosci (2010) 0.81
Lipopolysaccharide and a social stressor influence behaviour, corticosterone and cytokine levels: divergent actions in cyclooxygenase-2 deficient mice and wild type controls. J Neuroimmunol (2008) 0.79
Behavioral changes in systemic lupus erythematosus are of an autoimmune nature. Nat Clin Pract Rheumatol (2007) 0.77
GABA(A)-receptor-associated protein links GABA(A) receptors and the cytoskeleton. Nature (1999) 3.88
Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature (2000) 3.36
Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia. Mol Psychiatry (2006) 3.33
The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development (2001) 3.14
Constitutive endocytosis of GABAA receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons. J Neurosci (2000) 2.04
A force-plate actometer for quantitating rodent behaviors: illustrative data on locomotion, rotation, spatial patterning, stereotypies, and tremor. J Neurosci Methods (2001) 1.86
Assembly and cell surface expression of heteromeric and homomeric gamma-aminobutyric acid type A receptors. J Biol Chem (1996) 1.82
GABAA receptors are differentially sensitive to zinc: dependence on subunit composition. Br J Pharmacol (1991) 1.80
GABA(A) receptor cell surface number and subunit stability are regulated by the ubiquitin-like protein Plic-1. Nat Neurosci (2001) 1.66
The subcellular distribution of GABARAP and its ability to interact with NSF suggest a role for this protein in the intracellular transport of GABA(A) receptors. Mol Cell Neurosci (2001) 1.60
Regulation of GABAA receptor function by protein kinase C phosphorylation. Neuron (1994) 1.59
Biochemical characterization and localization of a non-N-methyl-D-aspartate glutamate receptor in rat brain. J Neurochem (1992) 1.58
Pharmacological and physiological characterization of murine homomeric beta3 GABA(A) receptors. Eur J Neurosci (1997) 1.54
Regulation of ligand-gated ion channels by protein phosphorylation. Adv Second Messenger Phosphoprotein Res (1999) 1.54
GABAB receptors: a new paradigm in G protein signaling. Mol Cell Neurosci (2000) 1.54
Ageing of the human corneal stroma: structural and biochemical changes. Biochim Biophys Acta (1992) 1.52
Expression of disrupted in schizophrenia 1 (DISC1) protein in the adult and developing mouse brain indicates its role in neurodevelopment. Mol Psychiatry (2004) 1.51
GABAA receptor phosphorylation and functional modulation in cortical neurons by a protein kinase C-dependent pathway. J Biol Chem (2000) 1.50
The C-terminal domains of the GABA(b) receptor subunits mediate intracellular trafficking but are not required for receptor signaling. J Neurosci (2001) 1.48
Cell surface stability of gamma-aminobutyric acid type A receptors. Dependence on protein kinase C activity and subunit composition. J Biol Chem (1999) 1.46
Adjacent phosphorylation sites on GABAA receptor beta subunits determine regulation by cAMP-dependent protein kinase. Nat Neurosci (1998) 1.45
Association of GABA(B) receptors and members of the 14-3-3 family of signaling proteins. Mol Cell Neurosci (2001) 1.37
GABA(B2) is essential for g-protein coupling of the GABA(B) receptor heterodimer. J Neurosci (2001) 1.37
cAMP-dependent phosphorylation of the tetrodotoxin-resistant voltage-dependent sodium channel SNS. J Physiol (1999) 1.34
Intracellular retention of recombinant GABAB receptors. J Biol Chem (1998) 1.33
Cyclic AMP-dependent protein kinase phosphorylation facilitates GABA(B) receptor-effector coupling. Nat Neurosci (2002) 1.33
Evidence that many of the DISC1 isoforms in C57BL/6J mice are also expressed in 129S6/SvEv mice. Mol Psychiatry (2007) 1.32
Phosphorylation of ligand-gated ion channels: a possible mode of synaptic plasticity. FASEB J (1992) 1.32
The protein MAP-1B links GABA(C) receptors to the cytoskeleton at retinal synapses. Nature (1999) 1.32
Supply of corneal tissue in the United Kingdom. Br J Ophthalmol (1990) 1.30
The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function. Mol Psychiatry (2010) 1.28
Subunit-specific association of protein kinase C and the receptor for activated C kinase with GABA type A receptors. J Neurosci (1999) 1.27
Cyclic AMP and synaptic activity-dependent phosphorylation of AMPA-preferring glutamate receptors. J Neurosci (1994) 1.24
Identification of amino acid residues within GABA(A) receptor beta subunits that mediate both homomeric and heteromeric receptor expression. J Neurosci (1999) 1.19
Assembly of GABAA receptors composed of alpha1 and beta2 subunits in both cultured neurons and fibroblasts. J Neurosci (1997) 1.19
Homomeric beta 1 gamma-aminobutyric acid A receptor-ion channels: evaluation of pharmacological and physiological properties. Mol Pharmacol (1996) 1.18
Generation of two forms of the gamma-aminobutyric acidA receptor gamma 2-subunit in mice by alternative splicing. J Neurochem (1991) 1.18
Analysis of GABAA receptor assembly in mammalian cell lines and hippocampal neurons using gamma 2 subunit green fluorescent protein chimeras. Mol Cell Neurosci (2000) 1.18
Proton sensitivity of the GABA(A) receptor is associated with the receptor subunit composition. J Physiol (1996) 1.16
LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric disease. Mol Cell Neurosci (2003) 1.11
Subcellular localization of gamma-aminobutyric acid type A receptors is determined by receptor beta subunits. Proc Natl Acad Sci U S A (1996) 1.10
D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade. J Neurophysiol (2000) 1.10
Disrupted in Schizophrenia-1 regulates intracellular trafficking of mitochondria in neurons. Mol Psychiatry (2010) 1.09
Progranulin expression in the developing and adult murine brain. J Comp Neurol (2010) 1.09
Cold hardening and transcriptional change in Drosophila melanogaster. Insect Mol Biol (2005) 1.09
Constitutive tyrosine phosphorylation of the GABA(A) receptor gamma 2 subunit in rat brain. Neuropharmacology (2001) 1.07
Modulation of neuronal and recombinant GABAA receptors by redox reagents. J Physiol (1999) 1.07
A functional comparison of the antagonists bicuculline and picrotoxin at recombinant GABAA receptors. Neuropharmacology (1996) 1.06
Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing properties. J Pharmacol Exp Ther (2005) 1.04
Conserved phosphorylation of the intracellular domains of GABA(A) receptor beta2 and beta3 subunits by cAMP-dependent protein kinase, cGMP-dependent protein kinase protein kinase C and Ca2+/calmodulin type II-dependent protein kinase. Neuropharmacology (1997) 1.04
The expression of GABA(B1) and GABA(B2) receptor subunits in the cNS differs from that in peripheral tissues. Neuroscience (2000) 1.03
Differential phosphorylation of intracellular domains of gamma-aminobutyric acid type A receptor subunits by calcium/calmodulin type 2-dependent protein kinase and cGMP-dependent protein kinase. J Biol Chem (1994) 1.03
Behavioral and biochemical characterization of a mutant mouse strain lacking D-amino acid oxidase activity and its implications for schizophrenia. Mol Cell Neurosci (2006) 1.01
Interaction of H+ and Zn2+ on recombinant and native rat neuronal GABAA receptors. J Physiol (1998) 1.01
Identification of a Zn2+ binding site on the murine GABAA receptor complex: dependence on the second transmembrane domain of beta subunits. J Physiol (1997) 0.99
Transcriptional regulation of neurodevelopmental and metabolic pathways by NPAS3. Mol Psychiatry (2011) 0.96
Subcellular localization and endocytosis of homomeric gamma2 subunit splice variants of gamma-aminobutyric acid type A receptors. Mol Cell Neurosci (1999) 0.94
Long-term survival of endothelium following transplantation of corneas stored by organ culture. Br J Ophthalmol (1992) 0.93
Identification of residues within GABA(A) receptor alpha subunits that mediate specific assembly with receptor beta subunits. J Neurosci (2000) 0.93
Neurotransmitter receptor trafficking and the regulation of synaptic strength. Traffic (2001) 0.92
Heteromeric assembly of GABA(B)R1 and GABA(B)R2 receptor subunits inhibits Ca(2+) current in sympathetic neurons. J Neurosci (2000) 0.92
GABAC receptor sensitivity is modulated by interaction with MAP1B. J Neurosci (2000) 0.91
Antidepressant effects of sleep deprivation require astrocyte-dependent adenosine mediated signaling. Transl Psychiatry (2013) 0.91
Synaptic targeting and regulation of GABA(A) receptors. Biochem Soc Trans (1999) 0.89
Central effects of urotensin-II following ICV administration in rats. Psychopharmacology (Berl) (2001) 0.89
Isolation of an aldehyde dehydrogenase involved in the oxidation of fluoroacetaldehyde to fluoroacetate in Streptomyces cattleya. Appl Environ Microbiol (2001) 0.88
Phenomenology of depression in children and adolescents. J Am Acad Child Adolesc Psychiatry (1988) 0.88
The major phosphorylation site of the NADPH oxidase component p67phox is Thr233. Biochem J (1999) 0.86
Platelet-derived growth factor receptor is a novel modulator of type A gamma-aminobutyric acid-gated ion channels. Mol Pharmacol (1995) 0.86
GABA receptor rho1 subunit interacts with a novel splice variant of the glycine transporter, GLYT-1. J Biol Chem (2000) 0.86
Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression. Neuropharmacology (2012) 0.86
Use of conjugate pneumococcal vaccine by United Kingdom neonatal intensive care units. Arch Dis Child Fetal Neonatal Ed (2005) 0.86
Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d-amphetamine: modulation by alpha2-adrenoceptors. Br J Pharmacol (1999) 0.82
The preclinical pharmacological profile of WAY-132983, a potent M1 preferring agonist. J Pharmacol Exp Ther (2000) 0.81
Synthesis and 5-hydroxytryptamine (5-HT) activity of 2,3,4,4a-tetrahydro-1H-pyrazino[1,2-a]quinoxalin-5-(6H)ones and 2,3,4,4a,5,6-hexahydro-1H-pyrazino[1,2-a]quinoxalines. Bioorg Med Chem Lett (2000) 0.81
Increased responsiveness of dopamine to atypical, but not typical antipsychotics in the medial prefrontal cortex of rats reared in isolation. Psychopharmacology (Berl) (2001) 0.81
Functional expression in the Xenopus oocyte of messenger ribonucleic acids encoding brain neurotransmitter receptors: further characterisation of the implanted GABA receptor. Neuropharmacology (1987) 0.80
Estrous cycle variations in GABA(A) receptor phosphorylation enable rapid modulation by anabolic androgenic steroids in the medial preoptic area. Neuroscience (2012) 0.80
Characterization of the anxiolytic properties of a novel neuroactive steroid, Co 2-6749 (GMA-839; WAY-141839; 3alpha, 21-dihydroxy-3beta-trifluoromethyl-19-nor-5beta-pregnan-20-one), a selective modulator of gamma-aminobutyric acid(A) receptors. J Pharmacol Exp Ther (2000) 0.80
Effects of osmotic stress on rabbit corneal endothelium. Cryobiology (1988) 0.80
Inhibition of GABAA receptor function by tyrosine kinase inhibitors and their inactive analogues. Mol Cell Neurosci (1998) 0.79
The alpha 1, alpha 2, and alpha 3 subunits of GABAA receptors: comparison in seizure-prone and -resistant mice and during development. J Mol Neurosci (1992) 0.79
Phosphorylation of p67phox in the neutrophil occurs in the cytosol and is independent of p47phox. FEBS Lett (1999) 0.78
Expression of D-serine and glycine transporters in the prefrontal cortex and cerebellum in schizophrenia. Schizophr Res (2008) 0.78
Differential effects of dopamine D1 and D2 receptor agonists on schedule-controlled behavior of squirrel monkeys. J Pharmacol Exp Ther (1995) 0.77
Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys. J Pharmacol Exp Ther (1996) 0.77
Complete absence of the permanent dentition: an autosomal recessive disorder. Am J Med Genet (1980) 0.77
Early loss of pit and fissure sealant: a clinical and SEM study. J Clin Pediatr Dent (1995) 0.77
WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depression. Br J Pharmacol (2010) 0.77
Comparison of two intracranial self-stimulation (ICSS) paradigms in C57BL/6 mice: head-dipping and place-learning. Behav Brain Res (2001) 0.76
Differential modulation of behavioral effects of cocaine by low- and high-efficacy D1 agonists. Psychopharmacology (Berl) (1997) 0.76
Preclinical characterization of WAY-211612: a dual 5-HT uptake inhibitor and 5-HT (1A) receptor antagonist and potential novel antidepressant. Br J Pharmacol (2009) 0.76
Gene expression studies of mRNAs encoding the NMDA receptor subunits NMDAR1, NMDAR2A, NMDAR2B, NMDAR2C, and NMDAR2D following long-term treatment with cis-and trans-flupenthixol as a model for understanding the mode of action of schizophrenia drug treatment. Brain Res Mol Brain Res (1998) 0.76
In vivo characterization of basal amino acid levels in subregions of the rat nucleus accumbens: effect of a dopamine D(3)/D(2) agonist. Neurochem Int (2001) 0.76
Cocaine-antagonist effects of limited-efficacy D1 agonists. NIDA Res Monogr (1992) 0.76
gamma-Aminobutyric acid type A receptor subunit assembly and sorting: gene targeting and cell biology approaches. Biochem Soc Trans (1997) 0.75